Metraipolis › archive › dc_4ff86caa02a9

A PD1-CD137L Fusion Protein More Potently Enhances Anti-Tumour Immune Responses Than Targeting PD-L1 and CD137 Separately — Europe PMC PMID:42572505

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42572505
DOI
10.1111/imm.70189
License (as archived)
solo-consultazione
Archived
2026-11-07T17:32:14.249Z
SHA-256 of the archived text
29aecaaeea46269019491f6ea58b772f9d700efa4383246f5d45d950e2f0cfcd
Stable URL of this page
https://metraipolis.com/documento/dc_4ff86caa02a9

How to cite

A PD1-CD137L Fusion Protein More Potently Enhances Anti-Tumour Immune Responses Than Targeting PD-L1 and CD137 Separately — Europe PMC PMID:42572505 — Europe PMC (en), https://europepmc.org/article/MED/42572505 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4ff86caa02a9 (Metraipolis archive dc_4ff86caa02a9, sha256 29aecaaeea46269019491f6ea58b772f9d700efa4383246f5d45d950e2f0cfcd)
BibTeX
@misc{dc4ff86caa02a9,
  title = {A PD1-CD137L Fusion Protein More Potently Enhances Anti-Tumour Immune Responses Than Targeting PD-L1 and CD137 Separately — Europe PMC PMID:42572505},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42572505},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4ff86caa02a9; sha256 29aecaaeea46269019491f6ea58b772f9d700efa4383246f5d45d950e2f0cfcd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42572505. Agents can read the archived copy with the MCP tool read_document.